Literature DB >> 8388410

Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment.

R Willemze1, R C Beljaards.   

Abstract

Primary cutaneous CD30 (Ki-1)-positive, large cell lymphomas (LCLs) represent a recently recognized group of cutaneous T-cell lymphomas with a favorable prognosis. The characteristic features of this cutaneous lymphoma are reviewed, differences with primary noncutaneous CD30+ LCLs emphasized, and its relation with other CD30+ cutaneous lymphoproliferative disorders, in particular lymphomatoid papulosis, is discussed. These primary cutaneous CD30+ LCLs, lymphomatoid papulosis, and related conditions represent a clinical and histologic continuum. A classification with practical guidelines for the management and treatment of patients within this spectrum of lymphoproliferative disorders is presented.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388410     DOI: 10.1016/0190-9622(93)70140-o

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  20 in total

1.  Regulation of CD30 antigen expression and its potential significance for human disease.

Authors:  M E Kadin
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

2.  [Neutrophil-rich, anaplastic CD30+ T cell lymphoma in conjunction with lymphomatoid papulosis].

Authors:  C M Slotosch; S Hörster; M Hertl; E Schultz
Journal:  Hautarzt       Date:  2010-06       Impact factor: 0.751

3.  Primary cutaneous CD 30+ anaplastic large cell lymphoma.

Authors:  S Devaji Rao; R Ravi; Meera Govindarajan
Journal:  Indian J Surg       Date:  2010-10-20       Impact factor: 0.656

Review 4.  CD30+ Lymphoproliferative Disorders of the Skin.

Authors:  Maxwell B Sauder; John T O'Malley; Nicole R LeBoeuf
Journal:  Hematol Oncol Clin North Am       Date:  2017-04       Impact factor: 3.722

Review 5.  Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.

Authors:  Meenal Kheterpal; Neha Mehta-Shah; Pooja Virmani; Patricia L Myskowski; Alison Moskowitz; Steven M Horwitz
Journal:  Curr Hematol Malig Rep       Date:  2016-06       Impact factor: 3.952

6.  Symmetrical lymphomatoid papulosis masquerading as pyoderma chancriformis of the eyelids.

Authors:  J E Boulton; J R Chesterton; D H McGibbon
Journal:  Br J Ophthalmol       Date:  1995-04       Impact factor: 4.638

Review 7.  CD30+ neoplasms of the skin.

Authors:  Madeleine Duvic
Journal:  Curr Hematol Malig Rep       Date:  2011-12       Impact factor: 3.952

8.  Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.

Authors:  David A Wada; Mark E Law; Eric D Hsi; David J Dicaudo; Linglei Ma; Megan S Lim; Aieska de Souza; Nneka I Comfere; Roger H Weenig; William R Macon; Lori A Erickson; Nazan Ozsan; Stephen M Ansell; Ahmet Dogan; Andrew L Feldman
Journal:  Mod Pathol       Date:  2010-12-17       Impact factor: 7.842

9.  Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study.

Authors:  J R Lopategui; L H Sun; J K Chan; M J Gaffey; H F Frierson; C Glackin; L M Weiss
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

10.  Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma.

Authors:  K N Konstantinov; B A Robbins; F T Liu
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.